Concord Medical Services Holding Limited (CCM) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CCM SEC filings page.
Concord Medical Services Holding Limited (CCM) reported $65.9M in revenue for fiscal year 2025, up 25.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 restored positive gross profit, but cash generation stayed negative amid a balance sheet with liabilities above assets.
The return to a5.6% gross margin in FY2025, after FY2024's negative reading, still left operating margin at-56.8% . Operating cash flow of-$28.9M and free cash flow of-$36.9M show the improvement had not become self-funded cash generation.
The
Liabilities of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Concord Medical Services Holding Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Concord Medical Services Holding Limited held $102.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $28.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Concord Medical Services Holding Limited scores 65/100 among other emerging companies.
Not available for Concord Medical Services Holding Limited, and counted as zero in the overall score.
Not available for Concord Medical Services Holding Limited, and counted as zero in the overall score.
Concord Medical Services Holding Limited reported revenue of $65.9M in fiscal year 2025, against $52.6M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Concord Medical Services Holding Limited scores 34/100 among other emerging companies.
Concord Medical Services Holding Limited's operations used $28.9M of cash in fiscal year 2025, against $54.5M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Concord Medical Services Holding Limited scores 59/100 among other emerging companies.
Concord Medical Services Holding Limited's cash, cash equivalents and investments came to $102.9M at the end of fiscal year 2025, against $1.2B of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Concord Medical Services Holding Limited scores 15/100 among other emerging companies.
Concord Medical Services Holding Limited scores -1.19, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($16.8M) relative to total liabilities ($1.2B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Concord Medical Services Holding Limited passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Concord Medical Services Holding Limited reported a net loss of $13.3M while operations used $28.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Concord Medical Services Holding Limited reported an operating loss of $37.4M against $21.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Concord Medical Services Holding Limited held $42.6M in cash against $352.6M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
CCM Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
CCM Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2410-K | Q4'2310-K | Q4'2210-K | Q4'2110-K | Q4'2010-K | Q4'1910-K | Q4'1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $936.3M+1.6% | $921.5M+8.1% | $852.7M-2.1% | $870.6M-10.9% | $977.6M+19.6% | $817.6M+32.4% | $617.3M-7.4% | $666.9M+25.2% |
| Current Assets | $134.7M-0.1% | $134.8M+55.1% | $86.9M-21.1% | $110.2M+20.1% | $91.7M-11.5% | $103.6M+155.3% | $40.6M-77.3% | $178.7M+4.6% |
| Cash & Equivalents | $42.6M+43.7% | $29.6M+261.7% | $8.2M-64.3% | $22.9M-7.1% | $24.7M-51.8% | $51.2M+379.9% | $10.7M-81.9% | $58.9M-38.9% |
| Short-Term Investments | $0-100.0% | $18.4M | $0 | $0 | $0 | $0 | $0-100.0% | $7.3M |
| Inventory | $6.6M+43.5% | $4.6M-19.4% | $5.7M-53.8% | $12.3M+105.8% | $6.0M+80.4% | $3.3M+430.8% | $624K+27.9% | $488K-49.5% |
| Accounts Receivable | $6.3M-10.1% | $7.0M-32.3% | $10.4M-45.2% | $18.9M-5.9% | $20.1M+69.3% | $11.9M+12.0% | $10.6M-16.2% | $12.6M-37.7% |
| Long-Term Investments | $60.3M-6.7% | $64.7M+16.4% | $55.6M-12.4% | $63.5M+3.6% | $61.3M+27.8% | $48.0M+414.2% | $9.3M-83.5% | $56.5M |
| Goodwill | $81.8M0.0% | $81.8M+3.8% | $78.8M-2.7% | $81.0M-3.9% | $84.4M+151.6% | $33.5M+4.0% | $32.3M+35.9% | $23.7M |
| Total Liabilities | $1.2B+0.2% | $1.2B+7.2% | $1.2B+0.9% | $1.1B-4.3% | $1.2B+29.8% | $919.2M+44.8% | $634.9M+5.2% | $603.3M+60.2% |
| Current Liabilities | $279.5M-4.0% | $291.2M+5.9% | $274.8M+69.1% | $162.6M+28.8% | $126.2M+60.8% | $78.5M-12.9% | $90.1M-28.8% | $126.6M-25.7% |
| Non-Current Liabilities | $392.2M-4.0% | $408.7M+23.2% | $331.8M-20.2% | $415.8M-1.2% | $420.8M+13.4% | $371.1M+45.1% | $255.8M+22.0% | $209.6M+1.6% |
| Long-Term Debt | $352.6M-4.5% | $369.0M+31.4% | $280.9M-21.6% | $358.3M+4.8% | $341.9M+13.3% | $301.6M+62.6% | $185.6M+156.4% | $72.4M+65.4% |
| Total Equity | -$300.7M+3.7% | -$312.4M-4.5% | -$298.9M-10.6% | -$270.3M-25.7% | -$215.0M-111.6% | -$101.6M-476.2% | -$17.6M-127.7% | $63.6M-55.7% |
| Retained Earnings | -$638.6M-6.6% | -$599.1M-4.6% | -$572.5M-4.8% | -$546.2M-6.2% | -$514.3M-36.6% | -$376.5M-46.8% | -$256.5M-43.0% | -$179.3M-32.7% |
CCM Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
CCM Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$300.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.48), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Concord Medical Services Holding Limited CCM | FY2025 | $65.9M | -$13.3M | -20.2% | $16.8M | 29/100 |
| Basel Medical Group Ltd BMGL | FY2025 | $8.9M | -$8.4M | -94.0% | $5.2M | 17/100 |
| American Shared Hospital Services AMS | FY2025 | $28.1M | -$1.6M | -5.5% | $9.0M | 37/100 |
| Cryo-Cell International Inc. CCEL | FY2025 | $31.6M | -$2.4M | -7.7% | $31.5M | 27/100 |
| ModivCare Inc. MODV | FY2024 | $2.8B | -$201.3M | -7.2% | $6.2M | 20/100 |
| NewGenIvf Group Limited NIVF | FY2025 | $4.7M | $9.9M | N/A | $2.9M | 31/100 |
Where Concord Medical Services Holding Limited Ranks
Frequently Asked Questions
What is Concord Medical Services Holding Limited's annual revenue?
Concord Medical Services Holding Limited (CCM) reported $65.9M in total revenue for fiscal year 2025. This represents a 25.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Concord Medical Services Holding Limited's revenue growing?
Concord Medical Services Holding Limited (CCM) revenue grew by 25.2% year-over-year, from $52.6M to $65.9M in fiscal year 2025.
Is Concord Medical Services Holding Limited profitable?
No, Concord Medical Services Holding Limited (CCM) reported a net income of -$13.3M in fiscal year 2025, with a net profit margin of -20.2%.
What is Concord Medical Services Holding Limited's EBITDA?
Concord Medical Services Holding Limited (CCM) had EBITDA of -$16.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Concord Medical Services Holding Limited have?
As of fiscal year 2025, Concord Medical Services Holding Limited (CCM) had $42.6M in cash and equivalents against $352.6M in long-term debt.
What is Concord Medical Services Holding Limited's gross margin?
Concord Medical Services Holding Limited (CCM) had a gross margin of 5.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Concord Medical Services Holding Limited's operating margin?
Concord Medical Services Holding Limited (CCM) had an operating margin of -56.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Concord Medical Services Holding Limited's net profit margin?
Concord Medical Services Holding Limited (CCM) had a net profit margin of -20.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Concord Medical Services Holding Limited's free cash flow?
Concord Medical Services Holding Limited (CCM) recorded an outflow of $36.9M in free cash flow during fiscal year 2025. This represents a 50.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Concord Medical Services Holding Limited's operating cash flow?
Concord Medical Services Holding Limited (CCM) recorded an outflow of $28.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Concord Medical Services Holding Limited's total assets?
Concord Medical Services Holding Limited (CCM) had $936.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Concord Medical Services Holding Limited's capital expenditures?
Concord Medical Services Holding Limited (CCM) invested $8.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Concord Medical Services Holding Limited's current ratio?
Concord Medical Services Holding Limited (CCM) had a current ratio of 0.48 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Concord Medical Services Holding Limited's return on assets (ROA)?
Concord Medical Services Holding Limited (CCM) had a return on assets of -1.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Concord Medical Services Holding Limited's P/E ratio?
Concord Medical Services Holding Limited (CCM) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $16.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Concord Medical Services Holding Limited's price-to-sales ratio?
Concord Medical Services Holding Limited (CCM) trades at 0.3x sales, its market capitalization divided by revenue of $65.9M revenue, FY2025. The market capitalization is $16.8M as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Concord Medical Services Holding Limited's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Concord Medical Services Holding Limited (CCM) held $102.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $28.9M over that year. Dividing the one by the other, the reported balance equals about 43 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Concord Medical Services Holding Limited's debt-to-equity ratio negative or not reported?
Concord Medical Services Holding Limited (CCM) has negative shareholder equity of -$300.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Concord Medical Services Holding Limited's Altman Z-Score?
Concord Medical Services Holding Limited (CCM) has an Altman Z-Score of -1.19, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Concord Medical Services Holding Limited's Piotroski F-Score?
Concord Medical Services Holding Limited (CCM) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Concord Medical Services Holding Limited's earnings high quality?
Concord Medical Services Holding Limited (CCM) reported a net loss of $13.3M while operations used $28.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Concord Medical Services Holding Limited cover its interest payments?
Concord Medical Services Holding Limited (CCM) reported an operating loss of $37.4M against $21.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Concord Medical Services Holding Limited?
Concord Medical Services Holding Limited (CCM) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.